Touchstone International Medical Science Co Ltd (688013) — Cash Flow Reinvestment Rate
Touchstone International Medical Science Co Ltd (688013) has a Cash Flow Reinvestment Rate of 0.31x as of September 2025, reinvesting CN¥8.28 Million (capex CN¥8.28 Million ) from operating cash flow of CN¥27.05 Million. Explore reinvestment intensity of Touchstone International Medical Science to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Touchstone International Medical Science Co Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Touchstone International Medical Science Co Ltd across 8 annual periods. Also explore 688013 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Touchstone International Medical Science Co Ltd (2017–2024)
Year-by-year capital reinvestment analysis for Touchstone International Medical Science Co Ltd. For live market cap and broader valuation context, see Touchstone International Medical Science market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.92x | CN¥155.74 Million | CN¥53.41 Million | CN¥41.94 Million | ▲ +107.8% |
| 2023 | 1.40x | CN¥116.38 Million | CN¥82.95 Million | CN¥18.41 Million | ▼ -8.0% |
| 2022 | 1.53x | CN¥76.90 Million | CN¥50.40 Million | CN¥47.67 Million | ▼ -15.3% |
| 2021 | 1.80x | CN¥109.80 Million | CN¥60.98 Million | CN¥9.21 Million | ▼ -71.3% |
| 2020 | 6.28x | CN¥264.40 Million | CN¥42.08 Million | CN¥7.29 Million | ▲ +1329.7% |
| 2019 | 0.44x | CN¥15.30 Million | CN¥34.82 Million | CN¥9.41 Million | ▼ -27.2% |
| 2018 | 0.60x | CN¥20.78 Million | CN¥34.44 Million | CN¥20.78 Million | ▼ -68.7% |
| 2017 | 1.93x | CN¥15.21 Million | CN¥7.88 Million | CN¥15.21 Million | — |